Drug recall

Apheresis PF24RT24 Plasma

FDA recall event 97114 · Class II · American National Red Cross (The)

Key facts

Event ID 97114
Recall numbers B-0367-2025, B-0368-2025, B-0369-2025, B-0370-2025, B-0371-2025, B-0372-2025
Recalling firm American National Red Cross (The)
Product type Biologics
Products Apheresis PF24RT24 Plasma, Apheresis Red Blood Cells, Leukocytes Reduced, Liquid Plasma, PF24 Plasma, Red Blood Cells, Leukocytes Reduced and 1 more
Classification Class II
Status Terminated
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Apheresis PF24RT24 Plasma, for which Babesia testing was not performed, were distributed., Apheresis Red Blood Cells, Leukocytes Reduced, for which Babesia testing was not performed, were distributed., Liquid Plasma, for which Babesia testing was not performed, was distributed., PF24 Plasma, for which Babesia testing was not performed, was distributed., Red Blood Cells, Leukocytes Reduced, for…
Initiation date May 10, 2023
Report date Jul 23, 2025
Termination date Jul 14, 2025
City Madison
State WI
Country United States
FEI number 2173028

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls